Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2015
16th World Conference on Lung Cancer
Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado
Presentation Date(s):- September 6 - 9, 2015
- Total Presentations: 2499
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
-
+
P1.02 - Poster Session/ Treatment of Localized Disease – NSCLC
- Type: Poster
- Track: Treatment of Localized Disease - NSCLC
- Presentations: 39
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.02-025 - Complete VATS Resection and Reconstruction of Carina and Trachea for Malignant or Benign Disease
09:30 - 09:30 | Author(s): J. He
- Abstract
Loading...
-
+
P1.04 - Poster Session/ Biology, Pathology, and Molecular Testing
- Type: Poster
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 116
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.04-069 - LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-Small Cell Lung Cancer Plasticity and Therapeutic Response
09:30 - 09:30 | Author(s): F. Li
- Abstract
Loading... -
+
P1.04-092 - LKB1 Inactivation Confers Human Lung Adenocarcinoma with Strong Plasticity for Squamous Transdifferentiation
09:30 - 09:30 | Author(s): X. Han
- Abstract
Loading... -
+
P1.04-098 - Mithramycin Is a Potential Therapeutic Agent for Elimination of Stem-Like Cells in Lung Cancer
09:30 - 09:30 | Author(s): H. Chen
- Abstract
Loading...
-
+
ORAL 13 - Immunotherapy Biomarkers
- Type: Oral Session
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 8
- Moderators:D. Kim
- Coordinates: 9/07/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
-
+
ORAL13.02 - Characterization of PD-L1 Expression Related to Unique Genes in NSCLC Tissue Samples
16:56 - 17:07 | Author(s): E.B. Garon
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 102
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.01-021 - Non-Inferior Progression Free Survival in NSCLC Patients Sensitive to EGFR TKI Receiving Low Dose versus Regular Dose of Gefitinib or Erlotinib
09:30 - 09:30 | Author(s): H. Chen
- Abstract
Loading... -
+
P2.01-102 - Phase I Study of Inhaled 5-Azacytidine in Patients with Advanced NSCLC
09:30 - 09:30 | Author(s): E. Yilmaz
- Abstract
Loading...
-
+
P2.04 - Poster Session/ Biology, Pathology, and Molecular Testing
- Type: Poster
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 109
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.04-049 - Efficacy of Focal Adhesion Kinase (FAK) Inhibition in RAS Mutant and EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): H. Zhang
- Abstract
Loading... -
+
P2.04-051 - The Pluripotency Factor Musashi-2 Is a Potential Target for Lung Cancer Therapy
09:30 - 09:30 | Author(s): M. Zhang
- Abstract
Loading...
-
+
MINI 16 - EGFR Mutant Lung Cancer 2
- Type: Mini Oral
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 15
- Moderators:G.J. Riely
- Coordinates: 9/08/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
-
+
MINI16.13 - A Randomized Controlled Trial of Erlotinib versus Gefitinib in Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations (CTONG0901)
17:55 - 18:00 | Author(s): J. Yang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MINI 18 - Radiation Topics in Localized NSCLC
- Type: Mini Oral
- Track: Treatment of Localized Disease - NSCLC
- Presentations: 15
- Moderators:D. Raben
- Coordinates: 9/08/2015, 16:45 - 18:15, 601+603
-
+
MINI18.08 - A Systematic Review of Comparative Effectiveness Studies of Surgery versus SABR in Early Stage Lung Cancer: How Good Is the Data?
17:25 - 17:30 | Author(s): A.V. Louie
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MINI 24 - Epidemiology, Early Detection, Biology
- Type: Mini Oral
- Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
- Presentations: 15
- Moderators:J. Creaney
- Coordinates: 9/08/2015, 16:45 - 18:15, 102+104+106
-
+
MINI24.12 - Assessment of PD-L1, TGF-β Expression and Tumor-Infiltrating CD8+ T Cells in Advanced Thymic Epithelial Tumors
17:50 - 17:55 | Author(s): J. Wang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 91
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.01-051 - Biomarker Analyses from a Phase II Trial of Nab-Paclitaxel/Carboplatin vs Emcitabine/Carboplatin in Advanced Squamous Cell Lung Cancer
09:30 - 09:30 | Author(s): J. Yang
- Abstract
Loading...
-
+
PLEN 04 - Presidential Symposium Including Top 4 Abstracts
- Type: Plenary
- Track: Plenary
- Presentations: 12
- Moderators:T. Mok
- Coordinates: 9/09/2015, 10:45 - 12:15, Plenary Hall (Bellco Theatre)
-
+
PLEN04.05 - Multiregion Whole Exome and Transcriptome Sequencing Defines the Genomic Spectrum of EGFR+ NSCLC and Reveals Novel Mechanisms of TKI Resistance
11:29 - 11:41 | Author(s): D.S. Tan
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
